Drugs / MDMA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07569159 | Jun 2026 → Apr 2027 expected | post-traumatic stress disorder | Sunstone Medical | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MDMA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07569159 ↗ |
| Route | Oral | “a 120 mg dose of oral MDMA followed by a supplemental dose of 60 mg MDMA” NCT07569159 ↗ |